NOS is present in the pineal gland and its function appears to be under photoneural regulation [9] .
The lowering effect of melatonin and thyroid hormones on serum cholesterol has also been documented showing a parallel effect on lipid metabolism [10] .
The aim of this study was to investigate the correlation between diurnal variations of melatonin and thyroid hormones, antioxidant status, and nitrate production in plasma.
water ad libitum. The rats received 7 daily subcutaneous (s.c) injections of melatonin (10 mg/kg) or PBS as the control 2 h before turning the lights off, and were decapitated under ether anesthesia (under ethical consideration) at 10:00 a.m. and 02:00 a.m.
Determination of melatonin in serum. The serum was estimated by ELISA (RE 540 21 IBLHamburg). Extraction columns were placed into glass tubes, 2ϫ1 ml of methanol (undiluted) was added, the solution centrifuged at 200ϫg for 1 min, and then 2ϫ1 ml of bidistilled water was added. After column preparation, 0.5 ml of standards, controls and samples were added to the columns and centrifuged at 200ϫg for 1 min. The columns were then washed with 2ϫ1 ml of 10% methanol in bidistilled water (v/v) and centrifuged at 500ϫg for 1 min. Next, the columns were placed into clean glass tubes and 1 ml methanol was added followed by centrifugation at 200ϫg for 1 min. The columns were removed from tubes, the methanol was evaporated by nitrogen, and samples were reconstituted in 0.15 ml of bidistilled water. Fifty microliters of each extracted standard, control and sample were pipetted into the appropriate wells. Fifty microliters of Melatonin-Biotine and 50 l antiserum were added into each well and the plate was shaken carefully. The plate was sealed with an adhesive foil and incubated for 18 h at ϩ4°C. Each well was then washed with assay buffer and 150 l of enzyme conjugate was pipetted into the wells followed by incubation of the plate for 120 min at room temperature.
Each well was washed three times with assay buffer, and 200 l of substrate solution was pipetted into each well. The plate was then incubated at room temperature for 1 h. Fifty microliters of stop solution was then pipetted into each well and the plate was read at an optical density of 405 nm with a microtiter plate reader. The lowest detectable level of the assay was 5 pg/ml.
Determination of thyroid hormones and thyroid-stimulating hormone. Hormones were measured by radioimmunoassay kits (Bio Bak, USA). The lowest detection limit of the assay was 0.011 IU/ml for TSH, 0.2 ng/ml for T 3 and 0.5 g/dl for T 4 .
Determination of the liver SOD activity. SOD activity was estimated by the spectrophotometric method (SOD-525, Bioxytech, France). Tissues were blotted on paper and weighted after washing in icecold 0.25 M sucrose. Tissues were then homogenized in ice-cold 0.25 M sucrose. Homogenates were centrifuged at 3,000ϫg for 10 min at ϩ4°C and supernatant was collected. Four-hundred microliters of icecold extraction reagent [ethanol-chloroform, 62.5 : 37.5 (v/v)] was added to 250 l of the supernatant, and the solution was centrifuged at 3,000ϫg for 10 min at ϩ4°C. The aqueous upper layer was then collected. Subsequently 40 l samples were taken from each supernatant (40 l water for the negative control), and 900 l diluting buffer at 37°C was added [50 mM 2-amino-2-methyl-1,3-propanediol/HCI, pHϭ 8.8, 0.11 mM diethylenetriaminepentaacetic acid (DTPA) as the chelating agent (Bioxytech)]. Thirty microliters of 1,4,6-trimethyl-2-vinylpropyl-trifluoromethano-sulphonate [R2 (Bioxytech)] was then added to separate the mercaptans (RSH groups), followed by energetic stirring to a vortex for 3-4 s and incubation in a thermal bath at 37°C (for 1 min). Thirty microliters of 5,6,6a,11b-tetrahydro-3,9,10-trihydroxybenzo-fluorene [R1 (Bioxytech)], the chromophore which will be self oxidized as a function of the SOD concentration, was then added, followed by stirring to a vortex (4-5 s). The samples were transferred to a quartz tube and the SOD activity was measured for absorbance at 525 nm (for 1 min). The experimental ratio V s /V c was obtained by reference tables which relate it to the units of activity of the enzyme: V s /V c ϭ1ϩ(SOD)/a(SOD)ϩb; V s ϭpercentage of sample with SOD, V c ϭmean of at least four controls, aϭ0.073, bϭ0.93. Hence: (SOD)ϭ0.93 (V s /V c -1)/1.073-0.073(V s /V c ) [11] . The resulting value is multiplied by the dilution factor and expressed as units of activity of per milliliter. The detection limit of the assay was 0.2 U/ml.
Nitrate measurement. The amount of total nitrate in the test samples was determined by modification of the procedure described by Bramen and Hendrix [12] using the purge system of Sievers (Model 280 NOA). A saturated solution of VCI 3 in 1 M HCI was prepared and filtered before use. Five milliliters of this reagent was added to a purge vessel and it purged with nitrogen for 5 to 10 min before use. The purge vessel was equipped with a cold-water condenser and a water jacket to permit heating of the reagent to 95°C using a circulating water bath. The HCI vapors were removed by a gas babbler containing 15 ml of 1 M NaOH. The gas flow rate into the chemiluminescence detector was controlled using a needle valve.
Sample and standards were injected into the purge vessel to react with the VCI 3 /HCI reagent, which converted nitrate and nitrite and s-nitroso compounds to NO. The NO produced was detected by ozone-induced chemiluminescence in the chemiluminescence detector. A standard curve was constructed using various concentrations of NaNO 3 (10-100 M). The detection limit of the assay was nanomolar to millimolar and assay sensitivity was ϳ1 pM.
Statistical analysis. All data are expressed as the meanϮstandard deviation (SD). A two-way factorial analysis of variance (ANOVA) test was applied. There were two levels of group factor: control and melatonin-treated. Two time factors were also involved: 02:00 a.m. and 10:00 a.m. (Table 2) .
RESULTS
Nighttime serum melatonin levels were found to be significantly higher than those of daytime levels in control (pϽ0.001) and melatonin-treated groups (pϽ0.02) (Tables 1 and 2) .
The SOD activity in the liver was increased at nighttime in control and melatonin-treated groups (pϽ0.001) ( Tables 1 and 2) .
Serum nitrate levels were decreased in the melatonin-treated and nighttime groups. This was a singificant difference between daytime and nighttime levels in the control and melatonin-injected groups (pϽ0.01 and pϽ0.05 respectively) ( Tables 1 and 2). T 3 , T 4 and TSH levels during nighttime were found to be significantly lower than those during daytime for the control and melatonin-injected groups (pϽ0.001). There were also significant difference between the levels of the control and melatonin-treated groups during in daytime and nighttime (pϽ0.05) ( Tables 1 and 2 ).
DISCUSSION
The action of melatonin is highly pleiotropic. It involves: firstly, direct effects via spesific binding sites in various peripheral tissues and cells of vertebrates, including immunomodulation; secondly, systemic influence on the cytoskeleton and nitric oxide formation, mediated by calmodulin; and thirdly, antioxidative protection [13] .
In vitro studies have demonstrated that melatonin is a scavenger of oxyradicals and peroxynitrite, and an inhibitor of NO [14] . Melatonin can inhibit NO production by reducing iNOS expression in leucocytes and inhibit catalytic activity of NOS in rat cerebellum and hypothalamus by a calmodulin-mediated mechanism [15] [16] [17] . Recent studies indicated that NO is involved in ischemic brain damage. In addition to the inhibition of neuronal NOS activity, the cytoprotective effect of melatonin during ischemia may be due to its ability to directly scavenge free radicals [18] . It is suggested that the inhibitory effect of melatonin on NO production may be responsible for the protective effect of the hormone on neuronal structures [18] . NO and Melatonin Is an Antioxidant cGMP rhythms in the frontal cortex of the chick are inversely related to the melatonin rhythm. When melatonin levels increase (at night or after melatonin injection) NO and cGMP levels decrease [18, 19] . In our study, serum nitrate levels decreased inversely related to the serum melatonin levels, and this is in agreement with previous studies [14, 18] . Thyroid hormones increase the basal rate of oxygen consumption in all tissues except the brain, gonads and spleen and dismutase levels, resulting in increased superoxide anion free radical formation. This may contribute to the deleterious effects of chronic hyperthyroidism and also decrease cholesterol levels [20] . Total light deprivation reduces serum T 4 . This effect is prevented by pinealectomy. In contrast, pinealectomy induced thyroid hypertrophy, an effect reversed by melatonin [21, 22] . Chronic night treatment with melatonin in the drinking water for mice significantly lowers night levels of T 3 and T 4 in peripheral blood [22] . In this study, it has been found that melatonin injection decreased the serum T 3 , T 4 , and TSH levels. This is in conjunction with other studies except for the results of TSH. As is expected, TSH should be increased after serum T 3 and T 4 levels decline, and this effect may be the result of direct melatonin effect on the hypothalamic plane.
SOD is a metalloenzyme which catalyses the dismutation of O 2 Ϫ · into O 2 and H 2 O 2 . It is important in the antioxidative defense mechanism [3] . NOS is also included in free radical generation in the absence of Larginine [23] . Melatonin, with its hepatic metabolite, 6-hydroxymelatonin sulfate, is a free radical scavenger. Rodriguez and co-workers have shown that SOD activity in ring dove leucocytes decreased in the presence of melatonin [3] . On the other hand, Antolin and co-workers reported that both Mn-SOD and Cu,Zn-SOD increased after treatment with melatonin in the harderian gland, and they suggested that melatonin may induce mRNA increments for SOD [24] . This is not the first report about melatonin on SOD activity, but we know that this is the first report showing the effect of diurnal variations of melatonin on liver SOD activity. In this study, increased SOD activity in the rat liver were determined. The antioxidant effect of melatonin may be the cause of increased SOD activity. Our findings were parallel with those of Genç and co-workers, who shown increased SOD activity in the liver after melatonin administration [25] .
In conclusion, the present results demonstrated that melatonin administration raises the serum melatonin level, reduces the serum nitrate and thyroid hormone levels and, as an antioxidant, increases the antioxidant capacity of tissues. 
